A Study on a New Tetravalent Dengue Vaccine (TDV) Formulation in Healthy Adults
Clinical trial NCT07047521 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07047521
- Sponsor
- Takeda
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-11-07
- Primary completion
- 2026-06-29
- Enrollment
- 496
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.